Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11624-11629

  Raposo, Rui Andre´ Saraiva ^a,d   Abdel Mohsen, Mohamed ^b,c   Deng, Xutao ^c   Hecht, Frederick M ^a   Pilcher, Christopher D ^a   Pillai, Satish K ^b,c   Nixon, Douglas F ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTB GENE; ADULT; APOBEC3C GENE; APOBEC3H GENE; ARTICLE; CD4+ T LYMPHOCYTE; CDKN1A GENE; CLINICAL ARTICLE; EIF2AK2 GENE; GAPDH GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HERC5 GENE; HOST RESTRICTION FACTOR GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IFITM GENE; IN VIVO STUDY; MALE; MOV10 GENE; PAF1 GENE; PPIA GENE; RNASEL GENE; RPLP0 GENE; RTF1 GENE; SAMHD1 GENE; SLFN11 GENE; T LYMPHOCYTE ACTIVATION; TRIM11 GENE; TRIM14 GENE; TRIM21 GENE; TRIM22 GENE; TRIM26 GENE; TRIM28 GENE; TRIM5 GENE; UBC GENE; UPREGULATION; VIRUS LOAD; VIRUS REPLICATION; CD4 LYMPHOCYTE COUNT; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LONGITUDINAL STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; VIROLOGY;

REPRESSOR PROTEIN; VIRUS RNA;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MALE; REPRESSOR PROTEINS; RNA, VIRAL; VIRAL LOAD;

EID: 84906969225     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01771-14     Document Type: Article

References (17)

1. Costello C, Tang J, Rivers C, Karita E, Meizen-Derr J, Allen S, Kaslow RA. 1999. HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS 13:1990-1991. http://dx.doi .org/10.1097/00002030-199910010-00031.
2. Gillespie GM, Kaul R, Dong T, Yang HB, Rostron T, Bwayo JJ, Kiama P, Peto T, Plummer FA, McMichael AJ, Rowland-Jones SL. 2002. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 16:961-972. http://dx.doi.org/10.1097 /00002030-200205030-00002.
3. Migueles SA, Laborico AC, Imamichi H, Shupert WL, Royce C, McLaughlin M, Ehler L, Metcalf J, Liu S, Hallahan CW, Connors M. 2003. The differential ability of HLA B*5701± long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77:6889-6898. http://dx.doi.org/10.1128/JVI.77 .12.6889-6898.2003.
4. McNeil AJ, Yap PL, Gore SM, Brettle RP, McColl M, Wyld R, Davidson S, Weightman R, Richardson AM, Robertson JR. 1996. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM 89:177-185. http://dx.doi.org/10 .1093/qjmed/89.3.177.
5. den Uyl D, van der Horst-Bruinsma IE, van Agtmael M. 2004. Progression of HIV to AIDS: a protective role for HLA-B27? AIDS Rev. 6:89-96.
6. Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT. 2005. Associations between KIR epitope combinations expressed by HLAB/- C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses. Mol. Immunol. 42:557-560. http: //dx.doi.org/10.1016/j.molimm.2004.07.041.
7. Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. 2008. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 22:1487-1491. http://dx.doi.org/10 .1097/QAD.0b013e3282ffde7e.
8. McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, O'Brien SJ, Pereyra F, Plummer FA, Poli G, Qi Y, Rucart P, Sandhu MS, Shea PR, Schuitemaker H, Theodorou I, Vannberg F, Veldink J, Walker BD, Weintrob A, Winkler CA, Wolinsky S, Telenti A, Goldstein DB, de Bakker PI, Zagury JF, Fellay J. 2013. Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog. 9:e1003515. http: //dx.doi.org/10.1371/journal.ppat.1003515.
9. Pillai SK, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene WC, Kovari H, Rauch A, Fellay J, Battegay M, Hirschel B, Witteck A, Bernasconi E, Ledergerber B, Gunthard HF, Wong JK. 2012. Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 in vivo. Proc. Natl. Acad. Sci. U. S. A. 109:3035-3040. http://dx.doi.org/10.1073/pnas .1111573109.
10. Harris RS, Hultquist JF, Evans DT. 2012. The restriction factors of human immunodeficiency virus. J. Biol. Chem. 287:40875-40883. http: //dx.doi.org/10.1074/jbc.R112.416925.
11. Raposo RA, Abdel-Mohsen M, Bilska M, Montefiori DC, Nixon DF, Pillai SK. 2013. Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells. J. Virol. 87:11924-11929. http: //dx.doi.org/10.1128/JVI.02128-13.
12. Raposo RA, Abdel-Mohsen M, Holditch SJ, Kuebler PJ, Cheng RG, Eriksson EM, Liao W, Pillai SK, Nixon DF. 2013. Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. J. Leukoc. Biol. 94:1051-1059. http://dx.doi.org/10.1189/jlb.0313150.
13. Abdel-Mohsen M, Raposo RA, Deng X, Liegler TJ, Sinclair E, Salama M, Ghanem HE, Hoh R, Wong J, Nixon DF, Deeks S, Pillai SK. 2013. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology 10:106. http://dx.doi.org/10.1186/1742-4690-10-106.
14. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. 2002. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16:1119 -1129. http://dx.doi.org/10.1097/00002030 -200205240-00005.
15. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42- 48. http://dx.doi.org/10.1001/jama.280.1.42.
16. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034. http://dx.doi.org/10.1186/gb-2002-3-7 -research0034.
17. Abdel-Mohsen M, Deng X, Liegler T, Guatelli JC, Salama MS, Ghanem Hel D, Rauch A, Ledergerber B, Deeks SG, Gunthard HF, Wong JK, Pillai SK. 2014. Effects of alpha interferon treatment on intrinsic anti- HIV-1 immunity in vivo. J. Virol. 88:763-767. http://dx.doi.org/10.1128 /JVI.02687-13.